GADO, FRANCESCA

GADO, FRANCESCA  

Dipartimento di Scienze Farmaceutiche  

Mostra records
Risultati 1 - 20 di 25 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Allosteric modulation of the cannabinoid 2 receptor confers seizure resistance in mice 1-mag-2021 Gado F. + Article (author) -
Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: Implications for drug discovery 1-ago-2019 Gado F. + Article (author) -
Anti-inflammatory activity of a cb2 selective cannabinoid receptor agonist: Signaling and cytokines release in blood mononuclear cells 1-gen-2022 Gado F. + Article (author) -
Bergamot leaf extract treats cardiorenal metabolic syndrome and associated pathophysiological factors in rats fed with a high sugar fat diet 1-ott-2022 Giovanna BaronAlessandra AltomareFrancesca GadoGiancarlo Aldini + Article (author) -
CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulators 1-feb-2022 Gado F. + Article (author) -
Cytotoxic Activity of Oleocanthal Isolated from Virgin Olive Oil on Human Melanoma Cells 1-gen-2016 Gado F. + Article (author) -
Design, Synthesis, and Biological Activity of New {CB}2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands 18-lug-2022 Francesca Gado + Article (author) -
Development of potent dual PDK1/AurA kinase inhibitors for cancer therapy: Lead-optimization, structural insights, and ADME-Tox profile 15-dic-2021 Gado F. + Article (author) -
The endocannabinoid system dual-target ligand N-cycloheptyl-1,2-dihydro-5-bromo-1-(4-fluorobenzyl)-6-methyl-2-oxo-pyridine-3-carboxamide improves disease severity in a mouse model of multiple sclerosis 15-dic-2020 Gado F. + Article (author) -
Identification of the First Synthetic Allosteric Modulator of the CB 2 Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief 10-gen-2019 Gado F. + Article (author) -
Liquid Chromatography–High-Resolution Mass Spectrometry (LC-HRMS) Profiling of Commercial Enocianina and Evaluation of Their Antioxidant and Anti-Inflammatory Activity 16-giu-2022 Larissa Della VedovaGiulio FerrarioFrancesca GadoAlessandra AltomareMarina CariniGiancarlo AldiniGiovanna Baron + Article (author) -
Medicinal Chemistry approach, pharmacology and neuroprotective benefits of CB2R modulators in neurodegenerative diseases 1-ago-2021 Gado F. + Article (author) -
Modification on the 1,2-dihydro-2-oxo-pyridine-3-carboxamide core to obtain multi-target modulators of endocannabinoid system 1-gen-2020 Gado F. + Article (author) -
Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor 15-dic-2017 Gado F. + Article (author) -
Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer 1-ott-2018 Gado F. + Article (author) -
Phenolic compounds in prevention and treatment of skin cancers: A review 24-mar-2021 Gado F. + Article (author) -
Polypharmacological profile of 1,2-dihydro-2-oxo-pyridine-3-carboxamides in the endocannabinoid system 25-giu-2018 Gado F. + Article (author) -
Polyphenols from Thinned Young Apples: HPLC-HRMS Profile and Evaluation of Their Anti-Oxidant and Anti-Inflammatory Activities by Proteomic Studies 15-ago-2022 Giulio FerrarioGiovanna BaronFRANCESCA GADOLarissa Della VedovaMarina CariniAlfonsina D'Amatogiancarlo aldiniAlessandra Anna Altomare + Article (author) -
Positive allosteric modulation of CB1 and CB2 cannabinoid receptors enhances the neuroprotective activity of a dual CB1R/CB2R orthosteric agonist 1-dic-2020 Gado F. + Article (author) -
PSNCBAM-1 analogs: Structural evolutions and allosteric properties at cannabinoid CB1 receptor 1-ott-2020 Gado F. + Article (author) -